3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Keratosis, Actinic
25
Uterine Cervical Dysplasia
13
Melanoma
10
Carcinoma, Basal Cell
10
Glioma
6
Glioblastoma
6
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Neoplasm Metastasis
4
Condylomata Acuminata
4
Precancerous Conditions
3
Papillomavirus Infections
3
Keratosis
3
Hutchinson's Melanotic Freckle
3
Vulvar Neoplasms
2
Urinary Bladder Neoplasms
2
Squamous Intraepithelial Lesions
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasms
2
Hemangioma, Capillary
2
HIV Infections
2
Ependymoma
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Warts
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Vaginal Neoplasms
1
Stomach Neoplasms
1
Interventions
Fluorouracil
26
Radiotherapy
17
Mitomycin
17
Cisplatin
12
Capecitabine
12
pembrolizumab
10
Cyclophosphamide
9
Radiation
8
Paclitaxel
8
fludarabine
7
Specimen Handling
7
Nivolumab
7
Carboplatin
7
Magnetic Resonance Spectroscopy
6
Cetuximab
6
Biopsy
6
Papillomavirus Vaccines
5
Drug Therapy
5
dehydroftorafur
4
aldesleukin
4
Vaccines
4
Radiotherapy, Intensity-Modulated
4
Irinotecan
4
Watchful Waiting
3
Taxes
3
Oxaliplatin
3
Observation
3
Light Coagulation
3
Ipilimumab
3
Interleukin-2
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Anus Neoplasms
×
Imiquimod
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts